跳转至内容
Merck
CN

T2408

Tolazamide

别名:

1-(Hexahydro-1H-azepin-1-yl)-3-(p-toluenesulfonyl)urea

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C14H21N3O3S
化学文摘社编号:
分子量:
311.40
UNSPSC Code:
12352200
PubChem Substance ID:
EC Number:
214-588-3
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

solubility

0.1 M NaOH: soluble 4.3 mg/ml, 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: soluble 2.7 mg/ml, DMSO: soluble 32.5 mg/ml, acetone: soluble 50 mg/ml, clear, colorless to light yellow

SMILES string

Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2

InChI

1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)

InChI key

OUDSBRTVNLOZBN-UHFFFAOYSA-N

Gene Information

human ... ALB(213), KCNJ1(3758)

Application

Tolazamide has been used as a KATP channel inhibitor to study changes in mean arterial blood pressure (MAP) in rat models of severe hemorrhagic shock2.

Biochem/physiol Actions

Stimulates pancreatic islet cells to secrete insulin; blocks ATP-sensitive K+ channels.

Preparation Note

Tolazamide is soluble in acetone at 50 mg/ml and yields a clear, colorless to light yellow solution. Furthermore, tolazamide is soluble in DMSO at 32.5 mg/ml, in 0.1 N NaOH at 4.3 mg/ml and in 45% (w/v)aqueous 2-hyroxypropyl-β-cyclodextrin at 2.7 mg/ml. It is insoluble in water.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

法规信息

新产品

此项目有


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

J H Karam et al.
Diabetes, 35(12), 1314-1320 (1986-12-01)
Patients with non-insulin-dependent diabetes mellitus (NIDDM) who have chronic hyperglycemia lose acute incremental insulin responses to glucose but are able to briskly respond to other beta-cell secretagogues. To investigate whether this is a defect specific for glucose or represents a
J D Lev et al.
Diabetes care, 10(6), 679-682 (1987-11-01)
We evaluated therapeutic usefulness of the second-generation sulfonylurea agents glyburide and glipizide in non-insulin-dependent diabetic patients who were secondary failures on chlorpropamide or tolazamide. Twenty patients were treated with glyburide, and 10 of them were subsequently treated with glipizide. Fasting
U M Kabadi et al.
Archives of internal medicine, 148(8), 1745-1749 (1988-08-01)
The influence of sulfonylurea drugs in enhancing the effect of endogenous insulin is well documented. Furthermore, combination therapy with sulfonylurea and insulin is effective in the treatment of type II diabetes mellitus. Therefore, to assess the efficacy of this type
G Severin
Journal of chromatography, 386, 57-63 (1987-01-16)
A method is described for the determination of N-nitrosohexamethyleneimine, a potential carcinogen, in tolazamide bulk drug and pharmaceutical dosage forms. The technique of trace enrichment high-performance liquid chromatography is employed to obtain accurate quantitation of the analyte at levels approaching
Lichenoid drug eruption from chlorpropamide and tolazamide.
C B Franz et al.
Journal of the American Academy of Dermatology, 22(1), 128-129 (1990-01-01)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持